In a patient with polymyalgia rheumatica, is the anemia of chronic disease typically normocytic or microcytic?

Anemia of Chronic Disease: Typically Normocytic, Can Be Microcytic

Anemia of chronic disease (ACD) is typically normocytic and normochromic, but can become microcytic as the disease progresses, particularly in the context of polymyalgia rheumatica and other chronic inflammatory conditions. 1, 2

Morphologic Classification

The anemia associated with chronic inflammatory conditions like polymyalgia rheumatica follows a predictable pattern:

• Initial presentation: Normocytic (MCV 80-100 fL) and normochromic 1, 3, 1
• Progressive disease: Can evolve to microcytic (MCV <80 fL) as inflammation persists 1, 2
• Mechanism: Chronic inflammation upregulates hepcidin, which sequesters iron in the reticuloendothelial system, creating functional iron deficiency that restricts erythropoiesis 2

Key Diagnostic Features in Inflammatory Conditions

When evaluating anemia in polymyalgia rheumatica or similar chronic inflammatory states, the laboratory pattern differs from pure iron deficiency:

Anemia of Chronic Disease (with or without functional iron deficiency):

• Serum ferritin >100 μg/L (reflecting inflammation and iron sequestration)
• Transferrin saturation <20%
• Normal to elevated inflammatory markers (ESR, CRP)
• Low reticulocyte count (inappropriately low for degree of anemia) 2, 4

Mixed picture (ACD + true iron deficiency):

• Serum ferritin 30-100 μg/L suggests combined deficiency 2, 4

Clinical Context: Polymyalgia Rheumatica

In polymyalgia rheumatica specifically, anemia of chronic disease is a common systemic manifestation driven by the underlying inflammatory process 5, 6. The inflammatory markers are typically markedly elevated, and the anemia reflects the systemic inflammatory burden rather than isolated nutritional deficiency 6.

Important Caveats

Do not assume microcytosis always means simple iron deficiency in inflammatory conditions. The presence of elevated inflammatory markers (CRP, ESR) and ferritin >100 μg/L distinguishes ACD from pure iron deficiency anemia, even when the MCV is reduced 1, 2. This distinction is critical because treatment approaches differ—ACD requires addressing the underlying inflammation, while iron deficiency requires iron supplementation.

The evolution from normocytic to microcytic anemia in chronic disease reflects prolonged iron restriction to developing erythrocytes, not depleted iron stores 1, 2.